Quantcast
New Mechanism Of Drug Resistance Discovered By Scientists

New Mechanism Of Drug Resistance Discovered By Scientists

Marla Vacek Broadfoot, Duke University Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs. These permanent mutations were once thought to be the only way...

Latest RNA interference Stories

2014-07-08 12:28:30

GAITHERSBURG, Md., July 8, 2014 /PRNewswire/ -- Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has received an Issue Notification from United States Patent and Trademark Office (USPTO) for a patent entitled "Multi-Targeted RNAi Therapeutics for Scarless Wound Healing of Skin" (US 8,735,567 B2, PCT/US2008/012498). This USPTO issuance, combined with a similar success for a Chinese patent (ZL 200880124132.8) provides a solid foundation and protection for the...

2014-07-07 08:27:41

MARLBOROUGH, Mass., July 7, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the appointment of Dr. Peter Campochiaro to its Scientific Advisory Board. Campochiaro is the George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience in the Johns Hopkins University...

2014-07-02 08:26:20

MARLBOROUGH, Mass., July 2, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the official opening of its new office and laboratory in the Marlborough Technology Center. The Company will host a ribbon-cutting ceremony on Wednesday, July 9, 2014 from 10:00 -12:00 p.m., at 257 Simarano...

2014-06-25 08:30:07

MARLBOROUGH, Mass., June 25, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the Company is set to join the Russell Microcap(®) Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, 2014, according to a preliminary list of...

2014-06-24 09:42:42

The Mount Sinai Hospital / Mount Sinai School of Medicine Biologists have long wondered if mammals share the elegant system used by insects, bacteria and other invertebrates to defend against viral infection. Two back-to-back studies in the journal Science last year said the answer is yes, but a study just published in Cell Reports by researchers at the Icahn School of Medicine at Mount Sinai found the opposite. In the Mount Sinai study, the results found that the defense system used...

2014-06-18 23:13:01

PeptiMed, a biopharmaceutical company focused on novel mechanisms of drug delivery, is pleased to announce the allowance of its claims for a targeted elastin-like polypeptide (ELP) nanoparticle for delivery of nucleotide therapeutic agents. Madison, Wisconsin (PRWEB) June 18, 2014 PeptiMed announced today that it was awarded United States patent No. 8,680,045, entitled, “Compositions of a peptide targeting system for treating cancer.” The invention describes a protein nanoparticle...

2014-06-09 08:28:22

Leadership team expanded following achievement of technology milestones SAN DIEGO, June 9, 2014 /PRNewswire/ -- Solstice Biologics LLC, a company focused on the targeting and delivery of nucleic acid therapeutics, today announced that Dr. Lou Tartaglia joined as President and Chief Executive Officer, and member of the Board of Directors. In addition, John Borgeson joined as Chief Financial Officer. The expansion of the leadership team follows the achievement of internal technology...

2014-05-28 23:08:58

Transparency Market Research added a new report "Global RNAI Technology Market: Analysis, Share, Size, Growth and Forecast 2010-2017" to its report store. Browse the full report: http://www.transparencymarketresearch.com/rnai-technology-market.html Albany, New York (PRWEB) May 28, 2014 The market for RNAi Technology will gain traction due to its applicability in various fields such as drug discovery, agriculture, therapeutics and others. RNAi Technology is classified as micro...

2014-05-27 08:28:04

MARLBOROUGH, Mass., May 27, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 at 8:00 a.m. EDT. Dr. Cauwenbergh will discuss the...

2014-05-22 08:29:07

WESTBOROUGH, Mass., May 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it received the Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd?rxRNA®). The patent, titled "Reduced Size Self-Delivering RNAi...


Latest RNA interference Reference Libraries

Blue Rose
2013-10-02 08:33:40

A Blue Rose is a flower of the genus Rosa belonging to the family Rosaceae that presents blue to violet pigmentation instead of the more common white, red, or yellow coloration. Blue roses are frequently portrayed in literature and art as a symbol of love and prosperity to those who seek it, but don’t exist in nature as a result of genetic limitations. In 2004, researchers utilized genetic modification to produce roses that contain the blue pigment delphinidin. After 13 years of...

Caenorhabditis elegans
2014-01-12 00:00:00

Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related